Molecules to Medicines intern program

The Victorian government is sponsoring the Molecules to Medicines intern program to provide practical on-the-job training and mentoring for researchers in technology transfer, translation and the commercial development of biomedical discoveries.  Further information can be found at www.molecules2medicine.org. All students/post docs interested in this program must submit a CV and a brief statement why they wish to pursue this course to Dr Steven Petratos (Central Clinical School) steven.petratos@monash.edu by 31 May 2014.


The program is open to current PhD students and postdoctoral early career researchers employed at participating institutions.  All Victorian biomedical research organisations, whether commercial or not, can apply.  Where possible, selected interns will work with their Business Development Offices on projects related to their own area of research.

The program is built on the successful model developed at the Walter and Eliza Hall Institute of Medical Research.  It offers multiple benefits to researchers and institutions, and provides:

• Practical experience with the parent institution in seven core areas related to the business of translating research – opportunity identification and analysis, intellectual property management, technology marketing communication, agreements, technology transfer administration, medicine development process and team membership, leadership and management.
• An expert series of 15-20 seminars for all interns on the topics associated with research commercialisation.

This course would be of particular interest to medically qualified PhD students who wish to become active clinician-scientists.

Enquiries

Further information can be found at www.molecules2medicine.org. All students/post docs interested in this program must submit a CV and a brief statement why they wish to pursue this course to Dr Steven Petratos (Central Clinical School) steven.petratos@monash.edu by 31 May 2014.